A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACO / acyl-CoA oxidase

[Related PubMed/MEDLINE]
Total Number of Papers: 125
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACO  (>> Co-occurring Abbreviation)
Long Form:   acyl-CoA oxidase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Short-term propamocarb exposure induces hepatic metabolism disorder associated with gut microbiota dysbiosis in adult male zebrafish. Acc1, Apo, Dgat, FAS, HK1, PK, PM, Ppar-alpha, TG
2018 Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver. ACC1, ATP, COXIV, CPT1A, FAS, NRF-1, PA, PGC-1alpha, PPARalpha, SREBP-1c, VDAC1
2018 AMPK activation by pterostilbene contributes to suppression of hepatic gluconeogenic gene expression and glucose production in H4IIE cells. AMPK, CPT1, G6Pase, PEPCK, PPAR-alpha
2018 Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells. ERalpha, HCC, PPARalpha
2018 Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay. CPT1, GP, NAFLD
2018 Hepatoprotective mechanism of freshwater clam extract alleviates non-alcoholic fatty liver disease: elucidated in vitro and in vivo models. ALT, AST, CPT, FAS, HFD, NASH, PGE2, PUFAs, SCD-1
2018 METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARdelta-dependent pathways in skeletal muscle of mice. AMPK, CPT1, FABP3, HFD, IkappaBalpha, IL-6, METRNL, NF-kappaB, PPARdelta
2018 Nutrigenomic studies on hilsa to evaluate flesh quality attributes and genes associated with fatty acid metabolism from the rivers Hooghly and Padma. FAS, PPARbeta, PPARgamma, PUFAs, SFA, WHC
2018 Pharmacologic activation of peroxisome proliferator-activating receptor-alpha accelerates hepatic fatty acid oxidation in neonatal pigs. ACCbeta, CPT I, KetoACoA, MCD, PPARalpha
10  2018 Tyrosine Residues 232 and 401 Play a Critical Role in the Binding of the Cofactor FAD of Acyl-coA Oxidase. FAD
11  2017 A High-Concentrate Diet Induced Milk Fat Decline via Glucagon-Mediated Activation of AMP-Activated Protein Kinase in Dairy Cows. AMPKalpha, GC, GCGR, HC, L-FABP, low-concentrate, NEFA, PPARalpha
12  2017 E2/ERbeta Inhibits PPARalpha to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma. PPARalpha
13  2017 Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study. CPT1, CYP7A1, FAS, HMG-CoAR, MDA, SOD, SREBP-1c
14  2017 Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. ACC, AMPK, CPT1, FAS, GPAT, HFS, NAFLD, p-ACC, p-AMPK, PPARalpha, RT-PCR, SREBP-1
15  2016 Black ginseng extract exerts anti-hyperglycemic effect via modulation of glucose metabolism in liver and muscle. CPT1a, G6Pase, GS, LGP, MCAD, PEPCK, STZ
16  2016 Implications of a peroxisome proliferator-activated receptor alpha (PPARalpha) ligand clofibrate in breast cancer. CBP-300, FASN, PPARalpha, SRC-1, SREBP-2
17  2015 Both butyrate incubation and hypoxia upregulate genes involved in the ruminal transport of SCFA and their metabolites. AE, COX, DRA, GLUT, HIF, MCT, NF, PAT
18  2015 Exercise Training Improves Whole Body Insulin Resistance via Adiponectin Receptor 1. AdipoR1, AdipoR2, HIT, pAMPK, PPARalpha, SC, SIRT1
19  2015 Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. ChREBP, CPT, FASN, IR, MSG, MTP, PPAR, Tau, TG
20  2015 Olive Leaf Extract Elevates Hepatic PPAR alpha mRNA Expression and Improves Serum Lipid Profiles in Ovariectomized Rats. PPARalpha, VLDL
21  2015 Transplacental induction of fatty acid oxidation in term fetal pigs by the peroxisome proliferator-activated receptor alpha agonist clofibrate. CPT, PPARalpha
22  2014 Chlorogenic acid and caffeine in combination inhibit fat accumulation by regulating hepatic lipid metabolism-related enzymes in mice. AMPK, CAT, CGA, FAS, IPAT
23  2014 Hepatic beta-oxidation and regulation of carnitine palmitoyltransferase (CPT) I in blunt snout bream Megalobrama amblycephala fed a high fat diet. CPT
24  2014 Increased expression of oxidative enzymes in adipose tissue following PPARalpha-activation. CPT1, FFA
25  2013 Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice. CA, CPT1, FAS, HFD, HOMA-IR, IGTT, L-FABP, PPAR-alpha, SCD1, SREBP-1c
26  2013 Dietary fat content and fiber type modulate hind gut microbial community and metabolic markers in the pig. CCA, HFD, SREBP-1c, VFA
27  2013 Several statins increase body and liver fat accumulation in a model of metabolic syndrome. CPT-1a, FAS, G6PDH, HR-LPL, ME
28  2012 AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity. ACC, AMPK, CPT, FAS, PPAR, SCD, SREBP
29  2012 Assessment of possible carcinogenicity of oxyfluorfen to humans using mode of action analysis of rodent liver effects. MOA
30  2012 Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation. BRE, FFAs, HF, NAFLD, ND, PPAR, TC, TG
31  2012 Catechins and Caffeine Inhibit Fat Accumulation in Mice through the Improvement of Hepatic Lipid Metabolism. CPT II, EGCG, FAS
32  2012 Cellular oxidative stress and peroxisomal enzyme activities in pediatric liver transplant patients. GPx, MDA, NOX, PBLs, PMP-70, SOD, VLCFAs
33  2012 Citrus ichangensis Peel Extract Exhibits Anti-Metabolic Disorder Effects by the Inhibition of PPARgamma and LXR Signaling in High-Fat Diet-Induced C57BL/6 Mouse. CIE, FAS, HF, LDL-C, LXR, PPARgamma, TC, TG
34  2012 Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARalpha induction in 3T3-L1 preadipocytes. AMPK, CaMKK, CoQ10, PPARalpha
35  2012 Regulation of lipid disorders by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats. CYP4A1, EEZZ, HFD, PPAR
36  2012 Regulation of obesity and lipid disorders by extracts from Angelica acutiloba root in high-fat diet-induced obese rats. AARE, CYP4A1, HFD, PPARalpha, SREBPs
37  2012 Vinegar-Baked Radix Bupleuri Regulates Lipid Disorders via a Pathway Dependent on Peroxisome-Proliferator-Activated Receptor-alpha in High-Fat-Diet-Induced Obese Rats. BW, CYP4A1, PPAR, SREBPs, VBRB
38  2011 Effects of trans-10,cis-12 CLA on liver size and fatty acid oxidation under energy restriction conditions in hamsters. CLA, CPT I, PPARalpha
39  2011 Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels. CYP4A1, HFD, PPARalpha, SREBPs
40  2011 Wild bitter gourd extract up-regulates mRNA expression of PPARalpha, PPARgamma and their target genes in C57BL/6J mice. L-FABP, LPL
41  2010 Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. CPT, FAS, G6PDH, ME, OA, SSC, TC, TG
42  2010 Perfluorooctanoic acid induces peroxisomal fatty acid oxidation and cytokine expression in the liver of male Japanese medaka (Oryzias latipes). CAT, GPx, PFOA, SOD
43  2010 Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. AST, CYP4A, MCAD, MPT, PPARalpha, qPCR, SREBP, TG
44  2009 A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance. 1-MOG, DAG, EE, FAT, TAG, UCP2
45  2009 Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. AMPK, CPT1, PPARalpha, UCP2
46  2009 Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats. ACC beta, ACS4, ACS5, EPA, FAS, GK
47  2009 Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. FA, LC, MC
48  2009 Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. CPT I, TAG, ZDF
49  2009 Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity. PGF, PPAR, ZDF
50  2008 Auraptene, a citrus fruit compound, regulates gene expression as a PPARalpha agonist in HepG2 hepatocytes. ACS, CPT1A, PPARalpha
51  2008 Dietary n-3 HUFA affects mitochondrial fatty acid beta-oxidation capacity and susceptibility to oxidative stress in Atlantic salmon. CPT, DHA, EPA, FA, HUFA, PL, PPAR, SOD
52  2008 Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha. ACMSD, EPA, PPAR, PUFA, RT-PCR
53  2008 Effect of Cheonggukjang supplementation upon hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, acyl-CoA oxidase and uncoupling protein 2 mRNA levels in C57BL/6J mice fed with high fat diet. ACS, CPT I, HD, ND, UCP2
54  2008 Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice. DIO, PPARs
55  2008 Fenofibrate prevents orotic acid--induced hepatic steatosis in rats. CPT1, LPL, OA, PPARalpha
56  2008 Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. MCD, NASH, PPAR, ROS, TGF
57  2008 Lemon Polyphenols Suppress Diet-induced Obesity by Up-Regulation of mRNA Levels of the Enzymes Involved in beta-Oxidation in Mouse White Adipose Tissue. HF, LF, LP, PPARalpha
58  2007 Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes. CPT1, EIA, GAGs, PGE2, PGs, PPAR, ROSI, TGF, TGF-beta1
59  2007 Feeding oxidized fat during pregnancy up-regulates expression of PPARalpha-responsive genes in the liver of rat fetuses. CYP4A1, L-CPT I, LCAD, MCAD, PPARalpha
60  2007 Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis. COX-2, IL-6, LPL, MCD, TNF-alpha
61  2007 Mutation of Tyr375 to Lys375 allows medium-chain acyl-CoA dehydrogenase to acquire acyl-CoA oxidase activity. MCAD
62  2006 Acyl-CoA oxidase activity from Beauveria bassiana, an entomopathogenic fungus. AT
63  2006 Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines. 13-HPODE, CPT1A, PPARalpha
64  2006 Effect of short-term and long-term fasting on transcriptional regulation of metabolic genes in rat tissues. CAT, CPT I, FAS, LCAH, NEFA, PDH, PDK4
65  2006 Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. CPT1, HDL, IL, L-FABP, MCD, MCP, NASH, NF, PPAR, TGF, TNF
66  2006 Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). EA, PPARs
67  2006 High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. EC, EL, HDL, PPARs, TNF
68  2006 Phospholipid molecular species, beta-oxidation, desaturation and elongation of fatty acids in Atlantic salmon hepatocytes: effects of temperature and 3-thia fatty acids. ASP, FA, NL, PC, PE, PI, PL, PS, TTA
69  2005 Different sensitivity of PPARalpha gene expression to nutritional changes in liver of suckling and adult rats. PEPCK, PPARalpha
70  2005 Metabolism of fatty acid in yeast: characterisation of beta-oxidation and ultrastructural changes in the genus Sporidiobolus sp. cultivated on ricinoleic acid methyl ester. ACDH, ECH, HAD
71  2005 Peroxisome proliferation in liver of rats fed oxidized frying oil. CYP4A, OFO, PP
72  2005 Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of beta-oxidation in Zucker fatty rats. ALADG, ALATG, DG, MCAD, PPARalpha, SREBP-1, TG
73  2004 The up-regulation of hepatic acyl-CoA oxidase and cytochrome P450 4A1 mRNA expression by dietary oxidized frying oil is comparable between male and female rats. CYP4A1, OFO, PP, PPARalpha
74  2003 Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy. CPT I, NF-kappaB, PPARalpha
75  2003 Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II. COUP-TF II, PPARgamma
76  2003 Peroxisome proliferator-activated receptor alpha is not the exclusive mediator of the effects of dietary cyclic FA in mice. CFAM, PPARalpha
77  2003 Up-regulation of fatty acid metabolizing-enzymes mRNA in rat spinal cord during persistent peripheral local inflammation. ACS, CFA, CNS
78  2002 Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. SD
79  2002 Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. NCoR, PPAR, RXR, SMRT
80  2002 Three-dimensional structure of the flavoenzyme acyl-CoA oxidase-II from rat liver, the peroxisomal counterpart of mitochondrial acyl-CoA dehydrogenase. MCAD
81  2001 Differential induction of peroxisomal populations in subcellular fractions of rat liver. DEHP
82  2001 Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators. PPRE
83  2001 Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 A1 genes in rats and activates PPARalpha. ALP, OFO, oxLDL, PPARalpha
84  2000 Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. AF-1, AF-2, KO, PKA, PPARs
85  2000 Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. PPs, TNF-alpha
86  2000 Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration. PPARalpha
87  2000 Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. ADD1, FAS, PPARalpha, PPARgamma
88  2000 Peroxisome proliferator-activated receptor-alpha expression in rat liver during postnatal development. apoC-III, PEPCK, PPARalpha
89  2000 Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. DEHP, PP, PPARalpha, PPREs
90  1999 Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. alphaAma, BEZA, CAT, CIPRO, CLO, DEHP, NAFE, PPs, TGF-beta, TNF-alpha
91  1999 Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. CLA, L-FABP, PPAR, SD
92  1999 Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. CYP4A1, L-FABP, PPARalpha, SPA
93  1999 Etomoxir, sodium 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate, up-regulates uncoupling protein-3 mRNA levels in primary culture of rat preadipocytes. CPT I, UCPs
94  1999 Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver. LC, PAL, VLC
95  1999 Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. HMG-CoA synthase, LPL, TTA
96  1999 Novel form of lipolysis induced by leptin. CPT1, FAS, FFA, NE, PPAR
97  1999 Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences. DEHP, PPARalpha, PPs
98  1999 Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. PP, PPARalpha, PPRE, PPREs
99  1998 Carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, and acyl-CoA oxidase activities in Atlantic salmon (Salmo salar). ---
100  1998 Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver. CYP4A1, FABP, PPAR